US 11866503
Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
granted A61KA61K2039/507A61K38/1793
Quick answer
US patent 11866503 (Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/507, A61K38/1793, A61K39/3955, A61K45/06